Prof. Aysha Habib Khan is Haiderali R Charania Professor of Chemical Pathology at Aga Khan University. She is founding head of biochemical genetics laboratory and founding Chair of newborn screening committee at Aga Khan University. She Co- Chair the IFCC/ISNS global taskforce of newborn screening committee and serves as treasurer and Executive council member of International Society of Newborn Screening (ISNS) and Academic Council member, Pakistan in Society of Study of Inborn Errors of Metabolism (SSIEM).

Professor Dianne Webster received her PhD from the University of London (UK, 1981) on aspects of the inborn error of metabolism hereditary orotic aciduria. She has been involved in newborn screening since 1986 and served as the Director of the New Zealand Newborn Metabolic Screening Programme since 1991. She is an honorary Professor at the Liggins Institute of the University of Auckland School of Medicine.. She has served in various capacities in several professional societies, notably the ISNS (in which she currently serves as an Asia Pacific representative and Vice-President) but also the Human Genetics Society of Australasia and the Clinical and laboratory Standards InstituteHer areas of interest in newborn bloodspot screening are programme evaluation (adding and removing disorders), disorder definition and counting and guideline development.

Dr. Carmencita D. Padilla is Professor Emeritus of College of Medicine, University of the Philippines (UP) Manila; Visiting Professor of the Mongolian National University of Medical Sciences; and Adjunct Professor of the SingHealth Duke -National University of Singapore Global Health Institute. Dr Padilla is pediatrician and geneticist who pursued a Master of Arts in Health Policy Studies. She is responsible for the lobby efforts for the passage of the Newborn Screening Act of 2004 (Republic Act No 9288) and the Rare Diseases Act of 2016 (Republic Act No 10747). Some of her key positions are: Chancellor of UP Manila (2014-2023); Founding Director of the Institute of Human Genetics and Newborn Screening Reference Center at the National Institutes of Health; Executive Director of the Philippine Genome Center; Board Member, Asia Pacific Alliance of Rare Disease Organizations (APARDO); Member, Global Commission to End the Diagnostic Odyssey for Children with a Rare Diseases and Commissioner, Lancet Commission on Rare

In recognition of her contributions in genetics and genomics in the country, the President of the Philippines conferred on her the title of National Scientist in 2023.

Dr. Sreehari M. Nair is a physician, public health expert, and healthcare strategist specializing in maternal and child health, trained in healthcare management, quality assurance, and developmental neurology. With over two decades of experience, he has led pioneering healthcare initiatives in Kerala, India, focusing on child survival, newborn screening, and digital health innovations in various administrative and program management roles.

Dr. Sreehari has worked with UNICEF as a maternal and child health consultant, contributing to policy development in immunization, acute malnutrition management, and newborn care. His work has earned Kerala State e-Governance Awards and the Chief Minister’s Innovation in Public Policy Award.

He is a member of a technical working group reviewing evidence to formulate a framework for WHO newborn screening in low—and middle-income countries, the state-level technical Committee on rare Diseases for formulating Policies and advising the Government of Kerala since 2018, the Cardiac Neurodevelopmental Outcome Collaborative (CNOC), and so on. He has been affiliated with the International Clearing House of Birth Defect Surveillance and Research (ICBDSR) since 2018.

Dr. Sreehari is currently working as an Assistant Surgeon under Kerala Health Services. He collaborates with various national and international organisations to continue his mission to improve healthcare accessibility and quality for vulnerable populations.